DV
Dividend Vision

AIFF — Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc. (AIFF)

Total return is -92.3% over the past 32.4 years, 3055.5 points behind SPY at 2963.2%. Its deepest 1-year drawdown was 79.0%.

Firefly Neuroscience develops and distributes medical devices and cloud-based platforms for high-resolution brain imaging and analysis, serving clinicians evaluating neurological and psychiatric conditions including depression, anxiety, ADHD, dementia, and traumatic brain injury. The company's primary offering is the Evoke System, which performs electroencephalographic assessments analyzed through its proprietary platform to generate clinical reports supporting diagnostic and treatment decisions. Distribution information for this equity is not currently available.

AIFF key facts

Asset type
Stock
Asset class
Equity
Inception date
04/06/1994
Distribution frequency
None
Last close
$1.09
Market cap
$17,102,444
Average volume
83800.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.51